Background. Gastroenteritis (GE) is a common reason for primary care consultation. Dutch clinical practice guidelines (CPG) recommend diagnostic faeces testing (DFT) only in primary care patients with severe illness, comprised immunity or increased transmission risk. For its superior accuracy, shorter turnaround time and ease of use, polymerase chain reaction (PCR)-based DFT has largely replaced conventional techniques. It is unknown whether this changed CPG adherence. Objective. To quantify the effect of PCR introduction on adherence to CPG indications for DFT in primary care patients with GE. Methods. We performed a cohort study using routine care data of 225 GPs. Episodes of GE where DFT was performed were extracted from electronic patient records. Presenting symptoms were identified and adherence to CPG indications for DFT assessed in two randomly drawn samples of each 500 patients, one from the period before PCR introduction (2010-11) and one after (2013). The association between PCR introduction and adherence was estimated using multivariable regression analysis. Results. In 88% of all episodes relevant presenting symptoms were reported, most often 'frequent watery stool' (58%) and 'illness duration >10 days' (40%). DFT was performed in 15% of episodes before PCR introduction and in 18% after. Overall, in 17% the DFT request was considered adherent to the CPG, 16% before PCR introduction and 18% after (adjusted OR 1.2, 95% CI 0.9-1.7). Conclusion. Overall adherence to CPG indications when requesting DFT in primary care patient with GE was 17%. Implementation of PCR-based DFT was not associated with a change in CPG adherence.
Introduction
Gastroenteritis (GE) is a major cause of morbidity in developed countries, with 2-8 in every 10 persons experiencing an episode of GE per year (1, 2) . Although most patients have an uncomplicated and self-limiting disease course (3) , in the Netherlands still 14 per 1000 patients annually consult their GP with complaints of GE (4) . To determine the causal pathogen and to guide potential antimicrobial treatment, the GP can request diagnostic faeces testing (DFT). Most clinical practice guidelines (CPGs) on management of GE define criteria for DFT primarily on pragmatism and consensus, as solid scientific evidence is lacking. In countries with a strong primary care system like the UK and the Netherlands (5), CPGs advocate restrictive use of DFT in patients presenting with GE symptoms, largely because of the favourable prognosis and the limited benefit of antibiotic treatment, even in GE with bacterial aetiology (3, 6, 7) . The Dutch primary care CPG on acute diarrhoea recommends to consider DFT only in patients with severe illness with fever, frequent watery or bloody/ mucosal stools; in patients with comprised immunity; or in those with an increased risk of disease transmission, such as in health care workers or food handlers (3, 6) . Consequently, DFT is not perceived as routine care for primary care patients with GE, but should only be 'considered' for high-risk patients. CPG adherence is, therefore, most appropriately assessed when focusing on patients receiving DFT, and not on those in which the GP refrained from testing. Two European studies in primarily outpatient children with GE demonstrated that full CPG adherence is low (3-34%) (8, 9) , and that adherence is most commonly violated by performing DFT in the absence of appropriate indications (8) . In two other studies, the average compliance with CPG recommendations among GPs in the Netherlands was estimated around 60% (10, 11) . However, one of these did not include the CPG on acute diarrhoea (10) , while the other quantified adherence as refraining from requesting DFT by the GP for all patients with GE (11). We, therefore, believe that these studies do not provide appropriate information to conclude to what extent Dutch GPs adhere to the current CPG for GE when requesting DFT in both children and adults.
Furthermore, in the last decade, molecular polymerase chain reaction (PCR)-based techniques have increasingly replaced conventional techniques like culture and microscopy (3, (12) (13) (14) . PCR allows for highly sensitive identification of multiple enteropathogens in a single stool sample with shorter turnaround times, resulting in improved user-friendliness when compared to conventional techniques (12, 14, 15) . We hypothesize that the advantages of PCR over conventional DFT make GPs more prone to routine use of DFT and could, therefore, increase inappropriate requests of DFT, consequently lowering CPG adherence. Various studies indicate that physicians encounter multiple barriers for adherence to CPGs and show that non-adherence is often intentional and supported by valid reasons (16, 17) , but do not elaborate on the effect of novel diagnostic techniques on CPG adherence.
Here, we quantify the adherence of Dutch GPs to the Dutch primary care CPG on acute diarrhoea when requesting DFT and the effect of PCR introduction on adherence.
Methods

Patients and setting
Patient data were gathered from the Utrecht General Practice Network (UGPN), a large dynamic primary care cohort containing routine care electronic medical records (EMRs) of 290,000 patients listed with 225 GPs in metropolitan area Utrecht in the Netherlands (reference date: 31 July 2012). Patients' laboratory records were gathered from Saltro Diagnostic Center. Approximately 96% of the UGPN GPs use the laboratory facilities of Saltro Diagnostic Center for their microbiological requests. Saltro Diagnostic Center replaced conventional enteropathogen DFT by molecular PCR DFT in April 2012.
All patients in the UGPN database consulting with an episode of GE between 2010 and 2013 were identified. GE was defined as a contact coded with International Classification of Primary Care (ICPC) D11 (diarrhoea), D70 (gastrointestinal infection) or D73 (suspected infectious GE). UGPN data of patients with a GE episode were linked to the laboratory data from Saltro using a pseudonimization procedure through a 'trusted third party'. We excluded all episodes in the year 2012 to allow for an adaptation period for GPs to PCR DFT. We also disregarded all episodes for which the full EMR consultation text was unavailable for technical reasons. For the assessment of CPG adherence, two random samples of GE episodes with DFT were drawn; a sample with 500 episodes from the period 2010-11 (when conventional DFT was performed) and a sample with 500 episodes from the period in 2013 (when PCR DFT was performed).
Data collection
For each episode (defined as the period of all ICPC coded contacts for GE with a maximum of 60 days between two contacts), we collected the patient's age, gender, ICPC coded comorbidities (Supplementary  Table S1 ), Anatomical Therapeutic Chemical (ATC) coded medication prescriptions (Supplementary Table S1 ), immune status (defined as presence of ICPC B72, B73, B74, B76, B90, U88, U99, T99, D97 and ATC H02X, L01X, L04X), number of GP contacts per disease episode, number of faeces test performed during the episode and the full consultation texts of the EMR.
Analysis
Patient characteristics of continuous variables were expressed as mean (including SD) and as proportions for dichotomous variables per period and overall. Patient characteristics between both periods were compared using the chi-square test (or the Fisher's exact test when cells contained less than 5 episodes) for dichotomous variables and the Mann-Whitney U-test for continuous and categorical variables. Presenting symptoms related to the disease episode were identified in the full EMR consultation text (Supplementary Table S2 ) and expressed as proportions.
To quantify CPG adherence for DFT, an assessment tool was developed, based on the indications stated in the 2007 Dutch primary care CPG on 'acute diarrhoea' (6) . Indicators of CPG adherence were 'severely ill patients', 'patients with compromised immunity' and 'patients with increased transmission risk'. Each indicator was assessed by making use of the full consultation texts, and relevant ICPC coded diseases and ATC coded drug prescriptions (see Supplementary Table S3 ). Adherence for DFT was scored positive when one or more indicators were present. Adherence proportions were calculated overall and for both the before and after samples. To ensure consistency, the primary assessment of the consultation texts was performed by one assessor (MB) and in accordance with the predefined set of characteristics (Supplementary Table S2 ) and indicators for CPG adherence (Supplementary Table S3 ). A second assessor (AS) performed random checks on the first assessor. Disagreement was solved by discussion and led to the final recording of CPG adherence indicators and presenting symptoms. The relation between testing modality (independent variable) and CPG adherence for DFT (dependent variable) was estimated as odds ratio (OR) with 95% confidence intervals (CIs) using a multivariable logistic regression model. To correct the effect estimate for potential differences between both periods (i.e. testing modality), we identified epidemiological risk factors for (consulting with) GE, such as age and gender (18) , factors that may influence clinical decision-making, such as number of contacts per episode, intestinal comorbidities, cardiovascular comorbidities, and factors that may influence disease initiation or course, such as diabetes mellitus, chronic obstructive pulmonary disease or asthma and antacid use. All confounding factors were entered into the model. For this analysis, we aimed to detect a minimally important difference of 10%. Assuming a pre-PCR adherence rate of 60% and the inclusion of 1000 patients, the minimally important difference could be detected with a power of 88%.
Data analysis were performed using SPSS (v21 for Windows) and Microsoft Excel (2010 for Windows).
Results
Patient characteristics
In total 18,677 episodes of GE were identified, 5541 episodes in 2010, 5654 in 2011 and 6810 in 2013. DFT was performed in 15% (n = 1712 over 2 years) and 18% (n = 1220) of the episodes in the periods before and after PCR introduction, respectively. The complete EMR consultation details were available for 69% of the episodes (n = 2012). In the period before PCR introduction, the mean age of patients with GE was 36 years and 59% was female. In the period after PCR introduction, the mean age was 33 years and 55% was female (Table 1) . Patients in the PCR period significantly were younger, had less often asthma and had more contacts per episode, when compared to before period with conventional DFT. Figure 1 shows the selection of the study population.
Clinical presentation
Specific presenting symptoms related to GE were identified in 88% of the patients with DFT (Table 2) . GPs recorded frequent watery stool (58%), illness duration >10 days (40%), a changed defecation pattern (29%), recent visit to (sub)tropics (22%), blood/mucous in stool (17%), abdominal discomfort (12%) and fever (11%) as most frequent clinical symptoms in patients receiving DFT. Concerns or a request of a patient was identified as reason for DFT in 8% of the patients.
Guideline adherence
Overall, in 17% of the GE episodes with DFT, the indication was considered in accordance with the CPG. During the periods before and after PCR introduction, in 6% and, respectively, 7% (χ 2 = 0.15, P = 0.70) of the episodes the patient was considered severely ill, in 10% and, respectively, 9% (χ 2 = 0.11, P = 0.74) immunocompromised, and 2% and, respectively, 4% (χ 2 = 2.88, P = 0.09) as having an increased transmission risk. After PCR introduction, the adherence rate did not significantly change, with a rate of 16% in the period before PCR introduction and 18% (χ 2 = 0.85, P = 0.36) in the period after PCR introduction (Table 1) . Also after adjustment for potential confounders (Table 3) , the use of PCR-based DFT in primary care was not associated with CPG adherence (adjusted OR 1.2, 95% CI 0.9-1.7).
Discussion
Summary
In patients in which DFT was requested for an episode of GE, the most common presenting symptoms were frequent watery stools (58%), illness duration >10 days (40%), changed defecation pattern (29%) and recent visit to (sub)tropics (22%). CPG adherence when requesting DFT in primary care patients with GE was 17% and not influenced by the introduction of PCR-based DFT in 2012.
Comparison with existing literature
Two studies on CPG adherence of Dutch GPs reported that around 60% of the decisions were in accordance with the guideline (10,11). The adherence rate for DFT of 17% in our study is comparatively low. However, whereas adequate clinical reasoning allows for deviation from professional guidelines, it cannot be concluded that the low level of CPG adherence should be judged as bad clinical practice in all cases (17) . Several factors could explain the relatively low adherence rate in our study. First, as highlighted in the Introduction Criteria A-C scored using a predefined algorithm; multiple criteria per disease episode are possible (Supplementary Table S3 ).
section, most CPGs on GE define criteria for DFT primarily on pragmatism and consensus, as solid scientific evidence is lacking. Possible ambiguity or inconsistency in these CPGs may partly explain the low adherence, as GPs may perceive the lack of evidence as a legitimation for a less strict interpretation of the indications (19, 20) . Secondly, perceived patient pressure is another important factor that influences CPG adherence. In an observational study in the UK, GPs were three times more likely to request diagnostic investigations when perceiving patient pressure (OR 3.18, 95% CI 1.31-7.70). Also, GPs only saw sufficient medical need in half (54%) of the patients who received diagnostic investigations (21) . We think that, in our study, patient pressure can be equally influential on CPG adherence for DFT, which may translate in the lack of a clear indication in the patient records for requesting DFT. Finally, whereas the aim of our study was to quantify adherence only in GE patients with DFT, it is probable that the assessment of DFT indications in all GE patients would have resulted in a higher degree of overall adherence. However, as DFT is not seen as routine care for primary care patients with GE, it does not seem appropriate to assess adherence criteria for episodes in which the GP refrained from testing. The main conclusion from our study is that the introduction of the more accurate and user-friendly PCR DFT does not change CPG adherence. This is remarkable, as one might expect that the availability of a faster and easier DFT procedure would increase the number of DFT request and subsequently reduce CPG adherence. Obviously, it is not only the low efficiency of the conventional procedure that results in low adherence.
Strengths and limitations
To our knowledge, this is the first study formally evaluating CPG adherence for DFT in primary care. We included multiple years and an adaptation period to PCR after its introduction. We analysed a large random sample from a dynamic primary care cohort with 225 GPs to assess CPG adherence, ensuring representativeness of the data.
Despite all efforts taken, some potential limitations need to be pointed out. Firstly, we were unable to gather all EMR records for all patients. However, we think that it is unlikely that this has influenced the evaluation of CPG adherence, as selection was dependent on the type of EMR software, and not to patient or GP characteristics. Secondly, our assessment of guideline adherence was based on the physician reported characteristics of the disease episode, together with ICPC and ATC coded immunocompromising disease and immunomodulating drug use, and the extent to which these related to the CPG recommended indications for DFT (Supplementary Table S3 ). This definition may not represent CPG adherence of the GP in all cases, as symptoms or risk factors may not have been recorded. Although this definition may have led to underestimate overall guideline adherence, we assume that its influence is similar in the before and after PCR introduction. In other words, the finding that the adherence did not change was not confounded by our definition. Furthermore, whereas we identified GE-related presenting symptoms in 88% of the episodes, the EMR records completeness was quite high. Nevertheless, without actually enquiring the GP, his or her motivations that were actually decisive in requesting DFT remain undetermined. However, such a qualitative study design is prone to induce the 'Hawthorne effect' and can lead to a transient increase in adherence during the study period due to observation of the GP (8, 9) . Finally, although we adjusted for various potential confounding factors when estimating the relation between testing modality and CPG adherence for DFT, residual confounding may still have affected our results. However, factors that are related to the periods that were compared (i.e. test modality), as well as whether DFT was performed in concordance with the guideline, are not plentiful and in our view largely included in the analysis or part of the assessment of CPG adherence.
Implications for research and practice
To increase CPG adherence, awareness should be raised in GPs on the indications for DFT. Most CPGs provide clear guidance and can be easily employed in daily practice. For example, short inservice training programmes on GE in children have demonstrated to be effective to improve knowledge of CPGs and adherence (8, 9) . Such training programmes could be easily adopted to be used for a wider population and in other countries. Furthermore, because CPG adherence increases when a solid empirical basis exists and when a higher effectiveness of the CPG is expected (19, 22, 23) , we aim to investigate the cost-effectiveness of DFT strategies and risk factors for unfavourable disease course. We anticipate that these studies can help improve diagnostic confidence of GPs in episodes with GE and limit the number of patients unnecessarily tested. Consequently, this will potentially increase the efficacy of DFT and lower health care-associated costs, without compromising the quality of clinical care.
